imperatorin has been researched along with histamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, HJ; Kim, HM; Oh, HA | 1 |
| Bai, H; He, H; He, L; Hou, Y; Hu, S; Wang, C; Wang, J; Wang, N; Zeng, Y; Zhang, Y | 1 |
2 other study(ies) available for imperatorin and histamine
| Article | Year |
|---|---|
Distinct effects of imperatorin on allergic rhinitis: imperatorin inhibits caspase-1 activity in vivo and in vitro.
Topics: Animals; Blotting, Western; Bone Marrow Cells; Caspase 1; Caspase Inhibitors; Cell Line; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Furocoumarins; Histamine; Histamine Release; Humans; I-kappa B Proteins; Inflammation; Mast Cells; Mice; Mice, Inbred BALB C; Nasal Mucosa; Ovalbumin; Peroxidase; Receptor-Interacting Protein Serine-Threonine Kinase 2; Receptor-Interacting Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Rhinitis, Allergic, Perennial | 2011 |
Imperatorin ameliorates mast cell-mediated allergic airway inflammation by inhibiting MRGPRX2 and CamKII/ERK signaling pathway.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line; Furocoumarins; Histamine; Humans; Hypersensitivity; Male; MAP Kinase Signaling System; Mast Cells; Mice, Inbred C57BL; Passive Cutaneous Anaphylaxis; Pneumonia; Receptors, G-Protein-Coupled | 2021 |